{
    "N/R/U": null,
    "Applicant": "Ablynx NV",
    "BLA Number": "761112",
    "Proprietary Name": "Cablivi",
    "Proper Name": "caplacizumab-yhdp",
    "BLA Type": "351(a)",
    "Strength": "11MG",
    "Dosage Form": "For injection",
    "Route of Administration": "Intravenous, Subcutaneous ",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "February 06, 2019",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": null,
    "Submission Type": "Original",
    "License Number": "2085",
    "Product Number": "001",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": "February 06, 2026"
}